Results 61 to 70 of about 113,618,068 (200)

The Role of a New Monoclonal Antibody Assay in the Detection of Recurrent Breast Cancer

The International Journal of Biological Markers, 1986
The immunoradiometric assay “CA 15-3”, recently developed to measure a breast tumor-associated antigen, gave a mean serum value of 13.8 U/ml (S.D. 6.2) for this antigen in 156 non-cancer controls (36 biopsies for a benign breast lesion and 120 healthy ...
Mariasilvia Tommasi, Beatrice Fantappié, Vito Distante, Luigi Cataliotti, Bruno Neri, Stefano Ciatto, Paolo Pacini   +6 more
doaj   +1 more source

Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer

Cureus
Breast cancer affects around 13% of women. Breast cancer gene 1 (BRCA1) carriers are prone to lung and lymph node metastasis, while breast cancer gene 2 (BRCA2) carriers tend to have bone metastasis. Findings of pulmonary nodules, mediastinal lymphadenopathy, and elevated markers such as cancer antigen (CA) 15-3 and CA 27-29 suggest metastatic disease.
Venkatram, Sindhaghatta, Duran, Maria, Fortuzi, Ked, Baqui, Aam, Luong, Thanh-ha, Diaz-Fuentes, Gilda   +5 more
openaire   +2 more sources

Comparison of breast cancer mucin (BCM) and CA 15-3 in human breast cancer [PDF]

, 1990
The Breast Cancer Mucin (BCM) enzyme immunoassay utilizes two monoclonal antibodies (Mab), M85/34 and F36/22, for the identification of a mucin-like glycoprotein in serum of breast cancer patients.
Nortier, J.W.R., Schornagel, J.H., Wall, E. van der, Blankenstein, M.A., Thijssen, J.H.H., Garcia, M.B.   +5 more
core  

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.

PLoS ONE, 2015
Background & aimsThe utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in patients with breast cancer remains controversial. The present study aims to investigate the prognostic value of preoperative serum CEA and
Yingbo Shao, Xianfu Sun, Yaning He, Chaojun Liu, Hui Liu   +4 more
doaj   +1 more source

CA 15–3: A Prognostic Marker in Breast Cancer

, 2000
CA 15–3 (also known as MUC1) is the most widely used serum marker in breast cancer. MUC1 is a large transmembrane glycoprotein which is frequently overexpressed and aberrantly glycosylated in cancer.
M.J. Duffy, S. Shering, N. O'Higgins, E. McDermott, F. Sherry   +4 more
core   +1 more source

CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer

, 2000
Background: Tumour markers along with other tests, may be useful in the assessment of the prognosis, monitoring response to treatment and early detection of metastases in breast cancer.
Kirazli, S, Ozyilkan, O, Baltali, E
core  

Exploring the Significance of Cluster Analysis on Time-Series Measurement of Plasma Cancer Antigen 15-3 in a Patient with Metastatic Breast Cancer

Applied Medical Informatics
Cancer Antigen 15-3 (CA 15-3) is a glycoprotein often linked to breast cancer. Elevated levels of CA 15-3, above the normal reference range of 30 U/mL (units per milliliter), are frequently found in the blood of patients with metastatic breast cancer ...
Alexandros CLOUVAS
doaj  

Comparison between CEA, TPA, CA 15/3 and Hydroxyproline, Alkaline Phosphatase, Whole Body Retention of Tc MDP in the follow-up of Bone Metastases in Breast Cancer

The International Journal of Biological Markers, 1990
The development of bone metastases in cancer can be monitored easily using three markers: 24 h urinary hydroxyproline excretion (HOP) (an index of osteoclastic activity), serum alkaline phosphatase (Alk.Ph.) (an index of osteoblastic activity) and 24 h ...
G. Francini, M. Montagnani, R. Petrioli, P. Paffetti, S. Marsili, V. Leone   +5 more
doaj   +1 more source

Time Series measurements of White Blood Cells (WBC) and plasma Cancer Antigen 15-3 (CA 15-3) in a patient with metastatic breast cancer, serving as a reference for assessing the clinical relevance of different clustering algorithms.

Applied Medical Informatics
Clustering is highly valuable for analyzing cancer marker time series data. In a recent study, the significance of the K-means clustering algorithm was examined for the first time in evaluating time-series measurements of plasma Cancer Antigen 15-3 (CA ...
Alexandros CLOUVAS
doaj  

Correlation between Serum and Tissue Markers in Breast Cancer Iraqi Patients

مجلة بغداد للعلوم, 2022
Breast cancer is the most prevalent malignancy among women worldwide, in Iraq it ranks the first among the population and the leading cause of cancer related female mortality.
doaj   +1 more source